Filing Details
- Accession Number:
- 0001209191-14-032370
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-08 18:00:53
- Reporting Period:
- 2014-05-07
- Filing Date:
- 2014-05-08
- Accepted Time:
- 2014-05-08 18:00:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1341235 | Aldeyra Therapeutics Inc. | ALDX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1604458 | Ben Bronstein | C/O Aldeyra Therapeutics, Inc. 15 New England Executive Park Burlington MA 01803 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-05-07 | 12,500 | $8.00 | 12,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Acquisiton | 2014-05-07 | 12,166 | $0.00 | 12,166 | $8.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
12,166 | 2024-05-06 | No | 4 | A | Direct |
Footnotes
- Exercisable in equal annual installments over three years of continuous service after May 7, 2014.